NovAliX at Targeted Protein Degradation

Meet NovAliX at the 6th Targeted Protein Degradation Summit in Boston, MA, USA, from October 30 to November 2, 2023. Organized by Hanson Wade, the Targeted Protein Degradation global forum covers the full drug development pipeline from discovery to the clinic. It enables protein degradation drug developers to network:

  • Novel E3 Ligase identification and validation
  • End-to-end landscape of PROTACs, molecular glues…
  • Breakthroughs with candidates drugging high-value targets and diseases within oncology, CNS and beyond
  • Essential blomarkers to rethink study design and guide clinical success of degrader candidates
  • Update on clinical candidates to address route to first PROTAC approval

More than 100 renowned speakers will hold conferences on ‘spearheading degrader therapeutics towards the first approval’.

If you are also attending, do not hesitate to contact our NovAlix experts at Targeted Protein Degradation Summit:

Dr Frank Moffat, Director Business Development

Dr Patrick Mollat, Senior Research Fellow Open Innovation

Contact us!